What is cmv

Overview

Cytomegalovirus (CMV) is a large, enveloped DNA virus belonging to the herpesvirus family (Herpesviridae). The name "cytomegalovirus" means "large cell virus" because the virus causes characteristic enlargement of infected cells. CMV is one of the most prevalent human viruses, with studies indicating that a significant portion of the global population carries the virus. Despite its prevalence, CMV often goes unnoticed because it typically causes no symptoms in healthy people.

Transmission and Infection

CMV spreads through contact with bodily fluids, including saliva, urine, blood, semen, and vaginal secretions. Transmission occurs through:

• Close personal contact with infected individuals
• Sexual contact
• Blood transfusions or organ transplantation
• Vertical transmission from mother to child during pregnancy
• Sharing of utensils, toothbrushes, or other objects with infected persons

The virus takes several weeks to months to spread through the body during primary infection.

Symptoms and Health Effects

In healthy individuals, CMV typically produces no symptoms or mild, cold-like symptoms that go unrecognized. However, in immunocompromised individuals, CMV can cause serious disease including pneumonia, esophagitis, colitis, retinitis, and encephalitis. Pregnant women with CMV infection can transmit the virus to their fetus, potentially causing congenital CMV disease with hearing loss, developmental delays, and intellectual disabilities.

Clinical Significance

CMV becomes a serious health concern primarily in immunocompromised patients, particularly those with HIV/AIDS who have low CD4 counts, organ transplant recipients, and cancer patients undergoing chemotherapy. Antiviral medications such as ganciclovir, foscarnet, and cidofovir are used to treat serious CMV infections. Prevention strategies for high-risk individuals include careful handling of bodily fluids and, in some cases, prophylactic antiviral therapy.

Diagnosis and Monitoring

CMV infection is diagnosed through blood tests that detect CMV-specific antibodies or PCR testing that identifies CMV DNA. Healthcare providers monitor CMV viral load in immunocompromised patients to detect reactivation early and initiate treatment before serious complications develop.